$113M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | NERV Minerva Neurosciences Inc | 2.2M | +31.4% | $12M | 10.7% |
| 2 | PMN Promis Neurosciences Inc | 620,319 | +49.8% | $8M | 7.2% |
| 3 | TRAX First Tracks Biotherapeutics | 284,287 | — | $6M | 5.1% |
| 4 | AXSM Axsome Therapeutics Inc. | 16,493 | — | $4M | 3.6% |
| 5 | ASMB Assembly Biosciences Inc | 140,000 | — | $4M | 3.4% |
| 6 | WHWK Whitehawk Therapeutics Inc | 817,939 | +0.0% | $4M | 3.3% |
| 7 | EWTX Edgewise Therapeutics Inc | 83,300 | −48.3% | $3M | 3.0% |
| 8 | CLYM Climb Bio Inc | 249,172 | — | $3M | 2.9% |
| 9 | KURA Kura Oncology Inc | 290,000 | — | $3M | 2.8% |
| 10 | CTMX Cytomx Therapeutics Inc. | 775,000 | −13.9% | $3M | 2.6% |
| 11 | AVTX Avalo Therapeutics Inc | 150,000 | — | $3M | 2.5% |
| 12 | PALI Palisade Bio Inc | 1.2M | — | $3M | 2.3% |
| 13 | SLDB Solid Biosciences Inc | 255,959 | −66.6% | $3M | 2.3% |
| 14 | ANTX An2 Therapeutics Inc | 526,315 | +0.0% | $3M | 2.3% |
| 15 | URGN Urogen Pharma Ltd | 69,183 | −65.8% | $3M | 2.3% |
| 16 | CATX Perspective Therapeutics Inc | 743,958 | −19.7% | $3M | 2.2% |
| 17 | IDYA Ideaya Biosciences Inc | 67,500 | — | $3M | 2.2% |
| 18 | IVA Inventiva Sa | 634,800 | −14.8% | $2M | 2.1% |
| 19 | ALMS Alumis Inc | 76,459 | −54.2% | $2M | 1.9% |
| 20 | OVID Ovid Therapeutics Inc | 624,561 | −77.8% | $2M | 1.5% |
| 21 | EPRX Eupraxia Pharmaceuticals Inc | 252,175 | −61.8% | $2M | 1.5% |
| 22 | IBIO Ibio Inc | 390,147 | — | $682,757 | 0.6% |
| 23 | TRAW Traws Pharma Inc | 786,236 | — | $663,033 | 0.6% |